PerkinElmer, Inc.

PerkinElmer SARS-COv-2 Serological Test Platforms

The Top 3 Advantages of the Product
1

Supports rapid decisions

2

Support population screening to monitoring the Covid-19 spread

3

Flexible solution to meet different throughput requirements

Wide variety of serological assays to match different needs

PerkinElmer offer a wide range of SARS-CoV-2 antibody tests to meet the different needs. Whether you may need to quickly assess the potential infectiousness of a person or you may want to run population screening to understand and monitor the disease spread, we can help you with the right product. Our CoviScreen kit is a rapid, non-clinical test, that can be run with a drop of blood having the results in 20 minutes. It detects all the Immunoglobulins, raising the possibility to detect early stage of infection. If you need a clinical test, but still very quick to take urgent decision, you can use our SuperFlex™ Anti-SARS-CoV-2 kit.

For high-throughput processing of samples, we can offer the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit. It is based on the robust and well-known DELFIA technology needing a drop of blood that can be absorbed on a filter paper (DBS). Such easy and cost-effective collection method allows to gather sample by remote and ship them to the clinical labs for testing, making the test extremely useful for population screening programs.

Applications
  • antibody tests

  • testing technology

Topics
  • genomics

  • detection systems

  • covid-19 detection

  • test platforms

Target Industries
PerkinElmer, Inc.
Get in Touch with the Supplier Now

PerkinElmer SARS-COv-2 Serological Test Platforms

More about PerkinElmer